You are leaving and open the following URL" of about "gb" news
gb: cl/dk/Novo Nordisk/Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1